These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 17046254)
1. Tetrahydroquinoline sulfonamides as gamma-secretase inhibitors. Asberom T; Bara TA; Clader JW; Greenlee WJ; Guzik HS; Josien HB; Li W; Parker EM; Pissarnitski DA; Song L; Zhang L; Zhao Z Bioorg Med Chem Lett; 2007 Jan; 17(1):205-7. PubMed ID: 17046254 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and evaluation of tetrahydroquinoline and pyrrolidine sulfonamide carbamates as gamma-secretase inhibitors. Guo T; Gu H; Hobbs DW; Rokosz LL; Stauffer TM; Jacob B; Clader JW Bioorg Med Chem Lett; 2007 Jun; 17(11):3010-3. PubMed ID: 17418571 [TBL] [Abstract][Full Text] [Related]
3. Design of potent inhibitors of human beta-secretase. Part 1. Freskos JN; Fobian YM; Benson TE; Bienkowski MJ; Brown DL; Emmons TL; Heintz R; Laborde A; McDonald JJ; Mischke BV; Molyneaux JM; Moon JB; Mullins PB; Bryan Prince D; Paddock DJ; Tomasselli AG; Winterrowd G Bioorg Med Chem Lett; 2007 Jan; 17(1):73-7. PubMed ID: 17046251 [TBL] [Abstract][Full Text] [Related]
4. Design of potent inhibitors of human beta-secretase. Part 2. Freskos JN; Fobian YM; Benson TE; Moon JB; Bienkowski MJ; Brown DL; Emmons TL; Heintz R; Laborde A; McDonald JJ; Mischke BV; Molyneaux JM; Mullins PB; Bryan Prince D; Paddock DJ; Tomasselli AG; Winterrowd G Bioorg Med Chem Lett; 2007 Jan; 17(1):78-81. PubMed ID: 17049233 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and structure-activity relationship of novel orally efficacious pyrazole/sulfonamide based dihydroquinoline gamma-secretase inhibitors. Truong AP; Aubele DL; Probst GD; Neitzel ML; Semko CM; Bowers S; Dressen D; Hom RK; Konradi AW; Sham HL; Garofalo AW; Keim PS; Wu J; Dappen MS; Wong K; Goldbach E; Quinn KP; Sauer JM; Brigham EF; Wallace W; Nguyen L; Hemphill SS; Bova MP; Bard F; Yednock TA; Basi G Bioorg Med Chem Lett; 2009 Sep; 19(17):4920-3. PubMed ID: 19660943 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors. Pu J; Kreft AF; Aschmies SH; Atchison KP; Berkowitz J; Caggiano TJ; Chlenov M; Diamantidis G; Harrison BL; Hu Y; Huryn D; Steven Jacobsen J; Jin M; Lipinski K; Lu P; Martone RL; Morris K; Sonnenberg-Reines J; Riddell DR; Sabalski J; Sun SC; Wagner E; Wang Y; Xu Z; Zhou H; Resnick L Bioorg Med Chem; 2009 Jul; 17(13):4708-17. PubMed ID: 19443228 [TBL] [Abstract][Full Text] [Related]
7. 2,6-Disubstituted N-arylsulfonyl piperidines as gamma-secretase inhibitors. Pissarnitski DA; Asberom T; Bara TA; Buevich AV; Clader JW; Greenlee WJ; Guzik HS; Josien HB; Li W; McEwan M; McKittrick BA; Nechuta TL; Parker EM; Sinning L; Smith EM; Song L; Vaccaro HA; Voigt JH; Zhang L; Zhang Q; Zhao Z Bioorg Med Chem Lett; 2007 Jan; 17(1):57-62. PubMed ID: 17055268 [TBL] [Abstract][Full Text] [Related]
8. Carbamate-appended N-alkylsulfonamides as inhibitors of gamma-secretase. Bergstrom CP; Sloan CP; Lau WY; Smith DW; Zheng M; Hansel SB; Polson CT; Corsa JA; Barten DM; Felsenstein KM; Roberts SB Bioorg Med Chem Lett; 2008 Jan; 18(2):464-8. PubMed ID: 18178084 [TBL] [Abstract][Full Text] [Related]
9. Nitrogen-appended N-alkylsulfonamides as inhibitors of gamma-secretase. Bergstrom CP; Sloan CP; Wang HH; Parker MF; Smith DW; Zheng M; Hansel SB; Polson CT; Barber LE; Bursuker I; Guss VL; Corsa JA; Barten DM; Felsenstein KM; Roberts SB Bioorg Med Chem Lett; 2008 Jan; 18(1):175-8. PubMed ID: 18023581 [TBL] [Abstract][Full Text] [Related]
10. Tricyclic sulfones as orally active gamma-secretase inhibitors: synthesis and structure-activity relationship studies. Sasikumar TK; Qiang L; Burnett DA; Cole D; Xu R; Li H; Greenlee WJ; Clader J; Zhang L; Hyde L Bioorg Med Chem Lett; 2010 Jun; 20(12):3632-5. PubMed ID: 20493690 [TBL] [Abstract][Full Text] [Related]
12. BACE1 inhibitory activities of enantiomerically pure, variously substituted N-(3-(4-benzhydrylpiperazin-1-yl)-2-hydroxypropyl) arylsulfonamides. Bertini S; Ghilardi E; Asso V; Granchi C; Minutolo F; Pineschi M; Di Bussolo V; Bortolato A; Moro S; Saba A; Macchia M Bioorg Med Chem; 2010 Nov; 18(22):7991-6. PubMed ID: 20934348 [TBL] [Abstract][Full Text] [Related]
13. Discovery of a novel sulfonamide-pyrazolopiperidine series as potent and efficacious gamma-secretase inhibitors (Part II). Ye XM; Konradi AW; Smith J; Aubele DL; Garofalo AW; Marugg J; Neitzel ML; Semko CM; Sham HL; Sun M; Truong AP; Wu J; Zhang H; Goldbach E; Sauer JM; Brigham EF; Bova M; Basi GS Bioorg Med Chem Lett; 2010 Jun; 20(12):3502-6. PubMed ID: 20529683 [TBL] [Abstract][Full Text] [Related]
14. Boom in the development of non-peptidic beta-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease. Silvestri R Med Res Rev; 2009 Mar; 29(2):295-338. PubMed ID: 18651582 [TBL] [Abstract][Full Text] [Related]
15. Discovery of a novel sulfonamide-pyrazolopiperidine series as potent and efficacious gamma-secretase inhibitors. Ye XM; Konradi AW; Smith J; Xu YZ; Dressen D; Garofalo AW; Marugg J; Sham HL; Truong AP; Jagodzinski J; Pleiss M; Zhang H; Goldbach E; Sauer JM; Brigham E; Bova M; Basi GS Bioorg Med Chem Lett; 2010 Apr; 20(7):2195-9. PubMed ID: 20207136 [TBL] [Abstract][Full Text] [Related]
16. Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease. Mayer SC; Kreft AF; Harrison B; Abou-Gharbia M; Antane M; Aschmies S; Atchison K; Chlenov M; Cole DC; Comery T; Diamantidis G; Ellingboe J; Fan K; Galante R; Gonzales C; Ho DM; Hoke ME; Hu Y; Huryn D; Jain U; Jin M; Kremer K; Kubrak D; Lin M; Lu P; Magolda R; Martone R; Moore W; Oganesian A; Pangalos MN; Porte A; Reinhart P; Resnick L; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Wang T; Woller K; Xu Z; Zaleska MM; Zeldis J; Zhang M; Zhou H; Jacobsen JS J Med Chem; 2008 Dec; 51(23):7348-51. PubMed ID: 19012391 [TBL] [Abstract][Full Text] [Related]
17. Structure guided P1' modifications of HEA derived β-secretase inhibitors for the treatment of Alzheimer's disease. Monenschein H; Horne DB; Bartberger MD; Hitchcock SA; Nguyen TT; Patel VF; Pennington LD; Zhong W Bioorg Med Chem Lett; 2012 Jun; 22(11):3607-11. PubMed ID: 22572583 [TBL] [Abstract][Full Text] [Related]
18. Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease. Kreft AF; Martone R; Porte A J Med Chem; 2009 Oct; 52(20):6169-88. PubMed ID: 19694467 [No Abstract] [Full Text] [Related]
19. 2-(N-Benzyl-N-phenylsulfonamido)alkyl amide derivatives as γ-secretase inhibitors. Parker MF; Barten DM; Bergstrom CP; Bronson JJ; Corsa JA; Dee MF; Gai Y; Guss VL; Higgins MA; Keavy DJ; Loo A; Mate RA; Marcin LR; McElhone KE; Polson CT; Roberts SB; Macor JE Bioorg Med Chem Lett; 2012 Nov; 22(22):6828-31. PubMed ID: 23046960 [TBL] [Abstract][Full Text] [Related]
20. N-Bridged bicyclic sulfonamides as inhibitors of gamma-secretase. Bowers S; Probst GD; Truong AP; Hom RK; Konradi AW; Sham HL; Garofalo AW; Wong K; Goldbach E; Quinn KP; Sauer JM; Wallace W; Nguyen L; Hemphill SS; Bova MP; Basi GS Bioorg Med Chem Lett; 2009 Dec; 19(24):6952-6. PubMed ID: 19879755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]